Non-muscle invasive bladder cancer has a high recurrence rate, but this treatment offers an additional way to stop it from progressing to a deadlier muscle invasive cancer.
Category: Cancer
Karen Ballen, MD, international expert in stem cell transplant and alternative donor transplant (transplant from donors that are not perfect matches), explains how it's possible.
We're accepting referrals for MR-Linac and cytoreductive surgery & hyperthermic intraperitoneal chemotherapy. Plus learn about upcoming CME opportunities.
UVA Health is among the first in the U.S. to offer BiTE therapy to small cell lung cancer patients in the outpatient setting.
Learn how this therapy can offer a critical second-line option for your stage 4 small cell lung cancer patients.
Targeting the transcription factors that drive certain cancers could lead to more effective, less toxic treatments.
This tool guides women on when to add MRI to their breast cancer screening regiment.
Dr. Duska's goal is for every GYN cancer patient at UVA Health to have the opportunity to participate in a clinical trial.
The discovery of an unexpected oocyte protein on the surface of cancer cells may lead to new treatments for pancreatic, ovarian, and other cancers.
When Jillian's leukemia relapsed, CAR T-cell therapy was her best option. Here's how the use case for CAR T in treating children's cancer is expanding.